Drug Profile
Research programme: metastatic melanoma therapeutics and diagnostics - SolaranRx
Alternative Names: SRX-1177Latest Information Update: 25 Apr 2023
Price :
$50
*
At a glance
- Originator University of New Mexico
- Class Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Melanocortin type 1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malignant melanoma
Most Recent Events
- 25 Apr 2023 Discontinued - Preclinical for Malignant melanoma (Diagnosis) in USA (IV)
- 25 Apr 2023 Discontinued - Preclinical for Malignant melanoma in USA (IV)
- 28 Oct 2018 No recent reports of development identified for preclinical development in Malignant-melanoma in USA (IV, Injection)